2
Publications
52
Citations
2
H-Index
2022
Active since
Affiliations
Emma de Vries is an author at AstraZeneca (United Kingdom).
Publications per year
2022–2023
2
2
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation
Alice Fletcher, Dean Clift, Emma de Vries et al. · Nature Communications · 2023 · 35 citations · Full text
Rows per page
1–2 of 2